Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

被引：102

作者：

Mancia, Giuseppe ^{[1
]}

Laurent, Stephane ^{[2
]}

Agabiti-Rosei, Enrico ^{[3
]}

Ambrosioni, Ettore ^{[4
]}

Burnier, Michel ^{[5
]}

Caulfield, Mark J. ^{[6
]}

Cifkova, Renata ^{[7
]}

Clement, Denis ^{[8
]}

Coca, Antonio ^{[9
]}

Dominiczak, Anna ^{[10
]}

Erdine, Serap ^{[11
]}

Fagard, Robert ^{[12
]}

Farsang, Csaba ^{[13
]}

Grassi, Guido ^{[14
]}

Haller, Hermann ^{[15
]}

Heagerty, Antony ^{[16
]}

Kjeldsen, Sverre E. ^{[17
]}

Kiowski, Wolfgang ^{[18
]}

Mallion, Jean Michel ^{[19
]}

Manolis, Athanasios ^{[20
]}

Narkiewicz, Krzysztof ^{[21
]}

Nilsson, Peter ^{[22
]}

Olsen, Michael H. ^{[23
]}

Rahn, Karl Heinz ^{[24
]}

Redon, Josep ^{[25
]}

Rodicio, Jose ^{[26
]}

Ruilope, Luis ^{[27
]}

Schmieder, Roland E. ^{[28
]}

Struijker-Boudier, Harry A. J. ^{[29
]}

Van Zwieten, Pieter A. ^{[30
]}

Viigimaa, Margus ^{[31
]}

Zanchetti, Alberto ^{[32
,33
]}

机构：

[1] Univ Milano Bicocca, San Gerardo Hosp, Med Clin, I-20052 Milan, Italy

[2] Hop Europeen Georges Pompidou, Dept Pharmacol, Paris, France

[3] Univ Brescia, Dept Med & Surg Sci, Clin Internal Med, Brescia, Italy

[4] Univ Bologna, Med Clin, Bologna, Italy

[5] CHU Vaudois, Div Nephrol & Hypertens, CH-1011 Lausanne, Switzerland

[6] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med, London, England

[7] Inst Clin & Expt Med, Dept Prevent Cardiol, Prague, Czech Republic

[8] Univ Ghent, Dept Cardiol & Angiol, B-9000 Ghent, Belgium

[9] Univ Barcelona, Dept Internal Med, Hosp Clin, Barcelona, Spain

[10] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland

[11] Istanbul Univ Cerrhpa, Sch Med, Istanbul, Turkey

[12] Univ Leuven, Dept Cardiovasc Dis, Hypertens & Cardiovasc Rehabil Unit, Louvain, Belgium

[13] St Imre Hosp, Cardiometab Ctr, Budapest, Hungary

[14] Univ Milano Bicocca, San Gerardo Hosp, Dept Clin Med & Prevent, I-20052 Milan, Italy

[15] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany

[16] Univ Manchester, Manchester Royal Infirm, Manchester M13 9WL, Lancs, England

[17] Ullevaal Univ Hosp, Dept Cardiol, Oslo, Norway

[18] Cardiovasc Ctr Zuerich, Zurich, Switzerland

[19] CHU Grenoble, F-38043 Grenoble, France

[20] Asklepe Gen Hosp, Athens, Greece

[21] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland

[22] Malmo Univ Hosp, Dept Clin Sci Med, Malmo, Sweden

[23] Glostrup Univ Hosp, Glostrup, Denmark

[24] Univ Munster, Dept Med, Div Nephrol & Hypertens, Munster, Germany

[25] Univ Valencia, Hosp Clin, Valencia, Spain

[26] Univ Complutense, Dept Med, E-28040 Madrid, Spain

[27] Hosp 12 Octubre, E-28041 Madrid, Spain

[28] Univ Erlangen Nurnberg, Med Klin, Erlangen, Germany

[29] Univ Limburg, Dept Pharmacol, NL-6200 MD Maastricht, Netherlands

[30] Univ Amsterdam, Amsterdam, Netherlands

[31] N Estonia Med Ctr, Ctr Cardiol, Tallinn, Estonia

[32] Univ Milan, Milan, Italy

[33] Ist Auxol Italiano, Milan, Italy

来源：

BLOOD PRESSURE | 2009年 / 18卷 / 06期

基金：

英国医学研究理事会;

关键词：

Antihypertensive treatment; cardiovascular risk; guidelines; hypertension; organ damage; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE CONTROL; END-POINT REDUCTION; TYPE-2; DIABETES-MELLITUS; CHRONIC HEART-FAILURE; ANGIOTENSIN RECEPTOR BLOCKERS; CONVERTING-ENZYME-INHIBITORS; MAJOR CARDIOVASCULAR EVENTS; ONSET ATRIAL-FIBRILLATION; LOW-DOSE ASPIRIN;

D O I：

10.3109/08037050903450468

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

[No abstract available]

引用

页码：308 / 347

页数：40

共 293 条

[1] Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].

Adler, AI ;

Stratton, IM ;

Neil, HAW ;

Yudkin, JS ;

Matthews, DR ;

Cull, CA ;

Wright, AD ;

Turner, RC ;

Holman, RR .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419

[2]

Rosei EA, 2007, DRUGS, V67, P1097

[3] Diabetes and cardiovascular events in hypertensive patients [J].

Alderman, MH ;

Cohen, H ;

Madhavan, S .

HYPERTENSION, 1999, 33 (05) :1130-1134

[4]

*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981

[5] Stroke and coronary heart disease in treated hypertension - a prospective cohort study over three decades [J].

Almgren, T ;

Persson, B ;

Wilhelmsen, L ;

Rosengren, A ;

Andersson, OK .

JOURNAL OF INTERNAL MEDICINE, 2005, 257 (06) :496-502

[6] Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study) [J].

Amar, J ;

Vaur, L ;

Perret, M ;

Bailleau, C ;

Etienne, S ;

Chamontin, B .

JOURNAL OF HYPERTENSION, 2002, 20 (04) :779-784

[7] Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy [J].

Ambrosioni, E ;

Leonetti, G ;

Pessina, AC ;

Rappelli, A ;

Trimarco, B ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 2000, 18 (11) :1691-1699

[8]

AMERY A, 1985, LANCET, V1, P1349

[9]

[Anonymous], 1991, JAMA, V265, P3255

[10]

[Anonymous], 1982, NEW ENGL J MED, V307, P976

← 1 2 3 4 5 6 7 8 9 10 →